drugset / Trial / NCT02305446
Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this trial is to assess the safety of a Meningococcal Group B Vaccine and to collect blood donation. Sera panel obtained from blood donations will be used as a control to measure the immunoresponse to the Meningococcal Group B Vaccine in other studies.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bexsero | Vaccine | 0.5 ml | Intramuscular |